Pharmaron Beijing Co., Ltd. (HKG: 3759)

Pharmaron Beijing Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	2,001	5,919	1,497	3,544	2,942	4,460
Short-Term Investments	-	179.36	613.24	1,080	-	-
Trading Asset Securities	596.88	621.98	745.36	1,555	910.01	183.45
Cash & Short-Term Investments	2,598	6,720	2,856	6,178	3,852	4,643
Cash Growth	-12.91%	135.30%	-53.77%	60.37%	-17.03%	1345.95%
Accounts Receivable	2,728	2,636	2,214	1,424	1,210	946.17
Other Receivables	164.88	80.98	71.16	92.43	33.38	45.36
Receivables	2,893	2,717	2,286	1,516	1,249	991.53
Inventory	1,196	1,013	1,041	680.04	281.62	157.4
Other Current Assets	411.19	423.68	352.82	269.05	157.76	152.22
Total Current Assets	7,098	10,874	6,536	8,644	5,540	5,944
Property, Plant & Equipment	10,538	10,062	8,464	5,811	3,799	2,882
Long-Term Investments	1,092	1,005	1,008	762.67	401.7	190.3
Goodwill	2,841	2,781	2,688	2,096	1,166	203.29
Other Intangible Assets	800.92	789.06	802.53	692.94	566.08	420.57
Long-Term Deferred Tax Assets	207.51	153.22	58.79	15.6	8.44	6.37
Long-Term Deferred Charges	675.86	520.47	496.38	171.6	234.27	204.84
Other Long-Term Assets	316.61	291.22	438.91	195.99	193.05	82.34
Total Assets	23,570	26,477	20,493	18,389	11,909	9,935
Accounts Payable	485.59	412.22	406.35	315.53	191.5	117.98
Accrued Expenses	609.74	805.65	784.92	626.21	472.44	289.91
Short-Term Debt	644.67	577.07	662.77	421.76	377.27	213.95
Current Portion of Long-Term Debt	451.99	150.34	74.94	60.54	8.88	65.54
Current Portion of Leases	-	185.32	164.03	95.29	83.92	85.31
Current Income Taxes Payable	248.53	184.55	145.87	81.34	27.62	28.65
Current Unearned Revenue	899.24	740.87	832.14	679.62	473.29	271.55
Other Current Liabilities	816.29	598.47	841.4	701.7	346.87	196.79
Total Current Liabilities	4,156	3,654	3,912	2,982	1,982	1,270
Long-Term Debt	4,330	8,200	4,454	4,423	394.81	542.03
Long-Term Leases	412.71	585.2	760.51	284.34	186.61	132.92
Long-Term Unearned Revenue	381.53	391.71	152.38	149.44	158.13	111.61
Long-Term Deferred Tax Liabilities	263.49	290.04	261.01	173.3	106.91	40.78
Other Long-Term Liabilities	-	117.58	112.09	81.56	146.81	-
Total Liabilities	9,544	13,239	9,653	8,094	2,975	2,097
Common Stock	1,787	1,787	1,191	794.18	794.39	794.39
Additional Paid-In Capital	5,191	5,222	5,254	6,008	6,028	5,965
Retained Earnings	6,885	5,818	4,574	3,554	2,131	1,078
Treasury Stock	-527.94	-463.45	-668.04	-301.83	-45.47	-72.78
Comprehensive Income & Other	51.71	193.72	197.26	74.15	-38.22	2.32
Total Common Equity	13,387	12,557	10,549	10,129	8,870	7,767
Minority Interest	638.87	681.25	291.25	166.07	63.42	70.95
Shareholders' Equity	14,026	13,238	10,840	10,295	8,934	7,838
Total Liabilities & Equity	23,570	26,477	20,493	18,389	11,909	9,935
Total Debt	5,840	9,698	6,117	5,285	1,051	1,040
Net Cash (Debt)	-3,242	-2,977	-3,260	893.04	2,801	3,604
Net Cash Growth	-	-	-	-68.12%	-22.27%	-
Net Cash Per Share	-1.83	-1.68	-1.84	0.49	1.57	2.42
Filing Date Shares Outstanding	1,768	1,787	1,787	1,787	1,787	1,787
Total Common Shares Outstanding	1,768	1,787	1,787	1,787	1,787	1,787
Working Capital	2,942	7,220	2,624	5,662	3,559	4,675
Book Value Per Share	7.57	7.03	5.90	5.67	4.96	4.35
Tangible Book Value	9,745	8,987	7,058	7,340	7,138	7,143
Tangible Book Value Per Share	5.51	5.03	3.95	4.11	3.99	4.00
Buildings	-	3,971	3,347	2,473	1,673	1,603
Machinery	-	5,149	4,265	2,919	2,194	1,764
Construction In Progress	-	2,633	1,671	1,374	820.58	217.27

Source: S&P Capital IQ. Standard template. Financial Sources.